Bristol-Myers Squibb Completes Sale Of Clairol To Procter & Gamble
NEW YORK, NEW YORK -- Bristol-Myers Squibb Company (NYSE:BMY) announced today that the sale of its Clairol beauty care subsidiary to The Procter & Gamble Company for $4.95 billion has been finalized. The divestiture, which was announced on May 21 and closed on November 15, is a key element of the company's growth strategy through a greater focus on its medicines business.
Bristol-Myers Squibb is an $18 billion pharmaceutical and related health care products company whose mission is to extend and enhance human life.
Most read news
Organizations
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.